 |
(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N’-bis(2-broethyl) diamidophosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2013-06-05 00:00:00 |
| Sponsor | EMD Serono;One Technology Place;Rockland, Massachusetts, 02370 |
